NIDA Research Monograph, Number 149 [Printed in 1995]
This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.
Download Monograph149.pdf - Medications Development for the Treatment of Pregnant Addicts and Their Infants (800 KB)
Table of Contents
Introduction-----1
C. Nora Chiang and Loretta P. Finnegan
Overview: Medications Development for the Treatment of Drug Abuse-----4
Frank Vocci, C. Nora Chiang, Lee Cummings, and Richard Hawks
Overview of the Effects of Abuse and Drugs on Pregnancy and Offspring-----16
Barry Zuckerman, Deborah Frank, and Elizabeth Brown
Clinical Management of Drug Dependency in Pregnancy-----39
James R. Woods, Jr.
Methadone Use During Pregnancy-----58
Margaret A.E. Jarvis and Sidney H. Schnoll
Treatment Options for Drug-Exposed Infants-----78
Stephen R. Kandall
Opioid Receptor Approaches for the Development of Medications for Pregnant Women-----100
Hazel H. Szeto
Pharmacokinetic and Pharmacodynamic Considerations for the Design and Screening of Potential Medications-----116
C. Lindsay DeVane
The Application of the Principles of Toxicology and Teratology in Evaluating the Risks of New rugs for the Treatment of Drug Addiction in Women of Reproductive Age-----130
Robert L. Brent
Drug Delivery Systems: Possible Applications in the Treatment of Drug Addiction-----185
Stella T. Chao
Clinical Trials of Pharmacologic Treatments in Pregnant Women-Methodologic Considerations-----201
Richard S. Schottenfeld
Legal and Ethical Issues-----224
Diane Aiken
Testing Medications for the Treatment of Addiction in Pregnancy: One Reviewer’s Opinion-----231
Curtis Wright
|
